|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2002-6-3
|
|
pubmed:abstractText |
We investigated heterotopic hepatocyte transplantation on biodegradable polymers as a potential treatment for end-stage liver disease. The primary problem has been insufficient engraftment of transplanted cells partly because of insufficient vascularization. Increasing vascularization through locally delivered angiogenic factors may increase angiogenesis and hepatocyte engraftment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
73
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1589-93
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12042644-Animals,
pubmed-meshheading:12042644-Biocompatible Materials,
pubmed-meshheading:12042644-Delayed-Action Preparations,
pubmed-meshheading:12042644-Fibroblast Growth Factor 2,
pubmed-meshheading:12042644-Hepatocytes,
pubmed-meshheading:12042644-Liver Circulation,
pubmed-meshheading:12042644-Male,
pubmed-meshheading:12042644-Neovascularization, Physiologic,
pubmed-meshheading:12042644-Rats,
pubmed-meshheading:12042644-Rats, Inbred Lew,
pubmed-meshheading:12042644-Time Factors,
pubmed-meshheading:12042644-Tissue Engineering
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Local delivery of basic fibroblast growth factor increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices.
|
|
pubmed:affiliation |
Department of Surgery, University of California at San Francisco, San Francisco, California 94143-0570, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
